Resultados de procura - Neil H. Bander
- Mostrando 1 - 20 Resultados de 39
- Go to Next Page
-
1
-
2
-
3
Targeted, Activatable, In Vivo Fluorescence Imaging of Prostate-Specific Membrane Antigen (PSMA) Positive Tumors Using the Quenched Humanized J591 Antibody–Indocyanine Green (ICG)... por Takahito Nakajima, Makoto Mitsunaga, Neil H. Bander, Warren D.W. Heston, Peter L. Choyke, Hisataka Kobayashi
Publicado 2011Artigo -
4
Cancer Patient T Cells Genetically Targeted to Prostate-Specific Membrane Antigen Specifically Lyse Prostate Cancer Cells and Release Cytokines in Response to Prostate-Specific Mem... por Michael Gong, Jean‐Baptiste Latouche, Anja Krause, Warren D.W. Heston, Neil H. Bander, Michel Sadelain
Publicado 1999Artigo -
5
-
6
Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer por Matthew I. Milowsky, David M. Nanus, Lale Kostakoğlu, Shankar Vallabhajosula, Stanley J. Goldsmith, Neil H. Bander
Publicado 2004Artigo -
7
-
8
-
9
-
10
-
11
Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen por Michael J. Evans, Peter Smith‐Jones, John Wongvipat, Vincent Navarro, Sae Kim, Neil H. Bander, Steven M. Larson, Charles L. Sawyers
Publicado 2011Artigo -
12
Vascular Targeted Therapy With Anti–Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors por Matthew I. Milowsky, David M. Nanus, Lale Kostakoğlu, Christine E. Sheehan, Shankar Vallabhajosula, Stanley J. Goldsmith, Jeffrey S. Ross, Neil H. Bander
Publicado 2007Artigo -
13
-
14
-
15
Na,K-ATPase β-Subunit Is Required for Epithelial Polarization, Suppression of Invasion, and Cell Motility por Sigrid A. Rajasekaran, Lawrence G. Palmer, Karina Quan, Jeffrey F. Harper, William J. Ball, Neil H. Bander, Alejandro Peralta Soler, Ayyappan K. Rajasekaran
Publicado 2001Artigo -
16
Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody por Jason P. Gleghorn, Erica D. Pratt, Denise Denning, He Liu, Neil H. Bander, Scott T. Tagawa, David M. Nanus, Paraskevi Giannakakou, Brian J. Kirby
Publicado 2009Artigo -
17
Anti–prostate‐Specific membrane antigen‐based radioimmunotherapy for prostate cancer por Scott T. Tagawa, Himisha Beltran, Shankar Vallabhajosula, Stanley J. Goldsmith, Joseph R. Osborne, Dan Matulich, K. Petrillo, Sarojben Parmar, David M. Nanus, Neil H. Bander
Publicado 2010Artigo -
18
Identification of transcripts encoding a parathyroid hormone-like peptide in messenger RNAs from a variety of human and animal tumors associated with humoral hypercalcemia of malig... por Kyoji Ikeda, Marguerite Mangin, Barbara E. Dreyer, Andrew C. Webb, James T. Posillico, Andrew F. Stewart, Neil H. Bander, Eleanor C. Weir, Karl Insogna, A E Broadus
Publicado 1988Artigo -
19
Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. por Marguerite Mangin, Andrew C. Webb, Barbara E. Dreyer, James T. Posillico, Kyoji Ikeda, Eleanor C. Weir, Andrew F. Stewart, Neil H. Bander, Leonard M. Milstone, David Barton
Publicado 1988Artigo -
20
Synergistic Cytotoxicity of Irinotecan and Cisplatin in Dual-Drug Targeted Polymeric Nanoparticles por Pedro M. Valencia, Eric M. Pridgen, Brian Perea, Suresh Gadde, Christopher J. Sweeney, Philip W. Kantoff, Neil H. Bander, Stephen J. Lippard, Róbert Langer, Rohit Karnik, Omid C. Farokhzad
Publicado 2012Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Internal medicine
Cancer
Prostate cancer
Immunology
Biology
Cancer research
Prostate
Antibody
Biochemistry
Glutamate carboxypeptidase II
Antigen
Monoclonal antibody
Oncology
Chemistry
Pathology
Gene
Nuclear medicine
Prostate-specific antigen
Radioimmunotherapy
Molecular biology
Biotechnology
In vivo
Toxicity
Urology
Androgen receptor
Cell
In vitro
Breast cancer
Cell biology